Statements

24 September 2021

Unitaid’s statement on the recommendation of casirivimab/imdevimab for COVID-19 treatment

View More

18 August 2021

Joint Statement from Unitaid and the World Health Organization (on behalf of the Access to COVID-19 Tools Accelerator) regarding availability of tocilizumab

View More

07 July 2021

Unitaid statement on WHO recommendations for tocilizumab and sarilumab

View More

19 June 2021

Unitaid’s Executive Board meets to discuss strategic direction in an evolving global health landscape at 38th meeting

View More

10 June 2021

UK government funding cuts: statement from Unitaid’s Chair and Executive Director

View More

13 May 2021

Unitaid supports new Global Initiative to end Cryptococcal Meningitis deaths by 2030

View More

06 May 2021

Unitaid statement on US support for IP waiver for COVID-19 vaccines

View More

28 April 2021

Unitaid and Wellcome statement regarding MSD’s global access plan for molnupiravir, a potential treatment for COVID-19 

View More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.